80 FR 53164 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 170 (September 2, 2015)

Page Range		53164-53164
FR Document		2015-21703

Federal Register, Volume 80 Issue 170 (Wednesday, September 2, 2015)

[Federal Register Volume 80, Number 170 (Wednesday, September 2, 2015)]
[Notices]
[Page 53164]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-21703]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Microbiology and Infectious 
Diseases Biological Resource Repository (MID-BRR).
    Date: September 25, 2015.
    Time: 8:30 a.m. to 12:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health; Room 2C100; 5601 Fishers 
Lane; Rockville, MD 20892; (Telephone Conference Call).
    Contact Person: Annie Walker-Abbey; Scientific Review Officer; 
Scientific Review Program; NIAID/NIH/DHHS; 5601 Fishers Lane, Room 
3E70A; Rockville, MD 20852; 240-627-3390; aabbey@niaid.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: August 27, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-21703 Filed 9-1-15; 8:45 am]
 BILLING CODE 4140-01-P

53164 Federal Register / Vol. 80, No. 170 / Wednesday, September 2, 2015 / Notices

ADDRESSES: Requests for copies of the DEPARTMENT OF HEALTH AND National Institute of Drug Abuse, the
patent application, inquiries, comments, HUMAN SERVICES National Institutes of Health (NIH) will
and other materials relating to the publish periodic summaries of proposed
contemplated co-exclusive license National Institutes of Health projects to be submitted to the Office of
should be directed to: Uri Reichman, Management and Budget (OMB) for
Ph.D., MBA, Licensing and Patenting National Institute of Allergy and review and approval.
Manager, Office of Technology Transfer, Infectious Diseases; Notice of Closed Written comments and/or suggestions
National Institutes of Health, 6011 Meeting from the public and affected agencies
Executive Boulevard, Suite 325, Pursuant to section 10(d) of the are invited to address one or more of the
Rockville, MD 20852–3804. Telephone: Federal Advisory Committee Act, as following points: (1) Whether the
(301) 435–4616; Facsimile: (301) 402– amended (5 U.S.C. App.), notice is proposed collection of information is
0220; Email: reichmau@mail.nih.gov. hereby given of the following meeting. necessary for the proper performance of
The meeting will be closed to the the function of the agency, including
SUPPLEMENTARY INFORMATION: This whether the information will have
technology is directed to gene public in accordance with the
provisions set forth in sections practical utility; (2) The accuracy of the
biomarkers for the diagnosis and agency’s estimate of the burden of the
potential treatment of acute ischemic 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and proposed collection of information,
stroke. Stroke is the third leading cause including the validity of the
of death in the United States, of which the discussions could disclose
methodology and assumptions used; (3)
87% are ischemic stroke and result in confidential trade secrets or commercial
The quality, utility, and clarity of the
death within 30 days in 8–12% of the property such as patentable material,
information to be collected; and (4)
cases. Currently, recombinant tissue and personal information concerning
Minimize the burden of the collection of
plasminogen activator (rtPA, trade name individuals associated with the contract
information on those who are to
alteplase), is the only FDA approved proposals, the disclosure of which
respond, including the use of
ischemic stroke treatment, and it is only would constitute a clearly unwarranted
appropriate automated, electronic,
effective when administered to patients invasion of personal privacy.
mechanical, or other technological
within three hours from the onset of Name of Committee: National Institute of collection techniques or other forms of
symptoms. Unfortunately, the median Allergy and Infectious Diseases Special information technology.
time from stroke symptom onset to Emphasis Panel; Microbiology and Infectious To Submit Comments and for Further
Diseases Biological Resource Repository Information: To obtain a copy of the
presentation to the emergency
(MID–BRR).
department is 3–6 hours. Although data collection plans and instruments,
Date: September 25, 2015.
advances in neuroimaging and clinical Time: 8:30 a.m. to 12:00 p.m. submit comments in writing, or request
management have helped with patient Agenda: To review and evaluate contract more information on the proposed
survival rates, these techniques are not proposals. project, contact: Albert Avila, Ph.D.,
infallible and at times result in Place: National Institutes of Health; Room Director, Office of Diversity and Health
misdiagnosis. The biomarkers identified 2C100; 5601 Fishers Lane; Rockville, MD Disparities, NIDA, NIH, 6001 Executive
in this technology may be used to 20892; (Telephone Conference Call). Blvd., Room 3106, Rockville, MD 20852,
develop a diagnostic testing device for Contact Person: Annie Walker-Abbey; or call non-toll-free number (301) 443–
Scientific Review Officer; Scientific Review 0441 or Email your request, including
determining stroke subtype in the field.
Program; NIAID/NIH/DHHS; 5601 Fishers your address to: aavila@nida.nih.gov.
The prospective co-exclusive license Lane, Room 3E70A; Rockville, MD 20852;
Formal requests for additional plans and
will be royalty bearing and will comply 240–627–3390; aabbey@niaid.nih.gov.
instruments must be requested in
with the terms and conditions of 35 (Catalogue of Federal Domestic Assistance
writing.
U.S.C. 209 and 37 CFR part 404. The Program Nos. 93.855, Allergy, Immunology,
Comment Due Date: Comments
prospective co-exclusive license may be and Transplantation Research; 93.856,
Microbiology and Infectious Diseases regarding this information collection are
granted unless within thirty (30) days best assured of having their full effect if
from the date of this published notice, Research, National Institutes of Health, HHS)
received within 60 days of the date of
the NIH receives written evidence and Dated: August 27, 2015.
this publication.
argument that establishes that the grant David Clary, Proposed Collection: NIDA Summer
of the license would not be consistent Program Analyst, Office of Federal Advisory Research Internship Program, 0925–
with the requirements of 35 U.S.C. 209 Committee Policy. NEW, National Institute on Drug Abuse,
and 37 CFR part 404. [FR Doc. 2015–21703 Filed 9–1–15; 8:45 am] NIDA, National Institutes of Health
Applications for a license in the field BILLING CODE 4140–01–P (NIH).
of use filed in response to this notice Need and Use of Information
will be treated as objections to the grant Collection: The NIDA Summer Research
of the contemplated co-exclusive DEPARTMENT OF HEALTH AND Internship program introduces high
license. Comments and objections HUMAN SERVICES school and undergraduate students of
submitted to this notice will not be underrepresented populations to
made available for public inspection National Institutes of Health substance abuse research through
and, to the extent permitted by law, will Proposed Collection; 60-Day Comment internships with NIDA grantees at
not be released under the Freedom of Request; Application Forms for the universities across the United States and
mstockstill on DSK4VPTVN1PROD with NOTICES

Information Act, 5 U.S.C. 552. NIDA Summer Research Internship Puerto Rico. Students intern with NIDA
Program (NIDA) principal investigators for 8–10 weeks
Dated: August 28, 2015.
during the summer. The internship
Richard U. Rodriguez, SUMMARY: In compliance with the experience may include laboratory
Acting Director, Office of Technology requirement of Section 3506(c)(2)(A) of experiments, formal courses, data
Transfer, National Institutes of Health. the Paperwork Reduction Act of 1995, collection, data analysis, patient
[FR Doc. 2015–21718 Filed 9–1–15; 8:45 am] for opportunity for public comment on recruitment, manuscript preparation,
BILLING CODE 4140–01–P proposed data collection projects, the literature reviews and library research.

VerDate Sep<11>2014 19:04 Sep 01, 2015 Jkt 235001 PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 E:\FR\FM\02SEN1.SGM 02SEN1

Document Created: 2018-02-26 10:10:43
Document Modified: 2018-02-26 10:10:43

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		September 25, 2015.
FR Citation		80 FR 53164

80 FR 53164 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 80, Issue 170 (September 2, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health